IN2014DN09522A - - Google Patents

Info

Publication number
IN2014DN09522A
IN2014DN09522A IN9522DEN2014A IN2014DN09522A IN 2014DN09522 A IN2014DN09522 A IN 2014DN09522A IN 9522DEN2014 A IN9522DEN2014 A IN 9522DEN2014A IN 2014DN09522 A IN2014DN09522 A IN 2014DN09522A
Authority
IN
India
Application number
Inventor
Nicoletta Maxia
Original Assignee
Nicoletta Maxia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46321277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN09522(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nicoletta Maxia filed Critical Nicoletta Maxia
Publication of IN2014DN09522A publication Critical patent/IN2014DN09522A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B2017/4216—Operations on uterus, e.g. endometrium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/80—Neurotransmitters; Neurohormones
    • C12N2501/825—Serotonine (5-HT); Melatonine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN9522DEN2014 2012-05-28 2014-11-12 IN2014DN09522A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000913A ITMI20120913A1 (en) 2012-05-28 2012-05-28 USE OF N-ACETHYL-5-METHOXY-RIPTAMIN OR ITS ANALOGUES TO ENCOURAGE THE EMBRYO PLANT MECHANISM, AND RELATIVE COMPOSITIONS AND MEANS OF CULTURE
PCT/EP2013/060872 WO2013178587A1 (en) 2012-05-28 2013-05-27 Use of n-acetyl-5-methoxytryptamine or analogues thereof, for promoting the mechanism of implantation of the embryo and related compositions and culture media

Publications (1)

Publication Number Publication Date
IN2014DN09522A true IN2014DN09522A (en) 2015-07-17

Family

ID=46321277

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9522DEN2014 IN2014DN09522A (en) 2012-05-28 2014-11-12

Country Status (18)

Country Link
US (2) US10034856B2 (en)
EP (1) EP2854790B1 (en)
JP (1) JP6401152B2 (en)
KR (2) KR20200036039A (en)
CN (2) CN104334167A (en)
AU (1) AU2013269728B2 (en)
BR (1) BR112014029116A2 (en)
CA (1) CA2869534A1 (en)
ES (1) ES2699807T3 (en)
HK (1) HK1201725A1 (en)
IL (1) IL235373B (en)
IN (1) IN2014DN09522A (en)
IT (1) ITMI20120913A1 (en)
MX (1) MX363007B (en)
RU (1) RU2657601C2 (en)
SG (1) SG11201406284WA (en)
WO (1) WO2013178587A1 (en)
ZA (1) ZA201407368B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2885523T3 (en) 2011-11-23 2021-12-14 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016014281A (en) 2014-05-22 2017-02-22 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies.
CA2975331A1 (en) * 2015-02-17 2016-08-25 Ares Trading S.A. Topical liquid composition comprising melatonin
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CN106474133B (en) * 2016-09-21 2019-07-26 北京市农林科学院 A preparation for improving the conception rate of dairy cows and its application
US12181462B2 (en) 2019-07-25 2024-12-31 Overture Life, Inc. Identification of viable human embryos
CN113215087A (en) * 2021-05-31 2021-08-06 广西壮族自治区畜牧研究所 Method for improving in-vitro maturation development rate of porcine oocytes by adopting agomelatine
AU2023309026A1 (en) * 2022-07-22 2025-03-06 Celmatix Inc. Compositions and methods for peripheral targeting of melatonin receptor agonist

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5749845A (en) 1995-01-25 1998-05-12 Iotek, Inc. Delivering an agent to an organ
KR101042660B1 (en) 1996-12-24 2011-06-20 바이오겐 아이덱 엠에이 인코포레이티드 Stable Liquid Interferon Formulations
KR100303662B1 (en) * 1998-06-10 2001-12-12 황기준 Method for preparing N-acetyl-5-methoxytrytamine
CA2597739A1 (en) * 2005-02-23 2006-08-31 M.B.T.L. Limited Culture device
CA2651862A1 (en) * 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US20080131496A1 (en) * 2006-09-22 2008-06-05 Guilford F Timothy Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non histamine related inflammatory skin changes
US8728532B2 (en) 2007-04-12 2014-05-20 Regents Of The University Of Minnesota Ischemia/reperfusion protection compositions and methods of using
CN102250832B (en) * 2011-05-30 2012-08-15 中国农业大学 Culture liquid for promoting ectogenesis of frozen embryo after thawing

Also Published As

Publication number Publication date
KR20150022886A (en) 2015-03-04
BR112014029116A2 (en) 2017-06-27
US10034856B2 (en) 2018-07-31
JP2015525210A (en) 2015-09-03
US20180303798A1 (en) 2018-10-25
CN104334167A (en) 2015-02-04
KR102095411B1 (en) 2020-04-01
US20150150847A1 (en) 2015-06-04
CN111035637A (en) 2020-04-21
KR20200036039A (en) 2020-04-06
AU2013269728B2 (en) 2017-10-05
SG11201406284WA (en) 2014-11-27
AU2013269728A1 (en) 2014-10-23
ITMI20120913A1 (en) 2013-11-29
EP2854790A1 (en) 2015-04-08
US10583118B2 (en) 2020-03-10
CA2869534A1 (en) 2013-12-05
RU2014150657A (en) 2016-07-20
ZA201407368B (en) 2016-03-30
MX363007B (en) 2019-03-04
IL235373B (en) 2018-02-28
HK1201725A1 (en) 2015-09-11
EP2854790B1 (en) 2018-08-29
RU2657601C2 (en) 2018-06-14
MX2014014123A (en) 2015-05-12
JP6401152B2 (en) 2018-10-03
ES2699807T3 (en) 2019-02-12
WO2013178587A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
BR112014017684A2 (en)
BR112014017635A2 (en)
BR112014017625A2 (en)
BR112014017659A2 (en)
BR112014017592A2 (en)
BR112014017646A2 (en)
BR112014017638A2 (en)
AR092201A1 (en)
BR112013027865A2 (en)
IN2014DN09522A (en)
BR112014017644A2 (en)
BR112014017634A2 (en)
BR112014017588A2 (en)
BR112014013184A8 (en)
BR112014017647A2 (en)
BR112014017627A2 (en)
BR112014017652A2 (en)
BR112014017630A2 (en)
BR112014017631A2 (en)
BR112014017641A2 (en)
BR112014024291A2 (en)
BR112014017671A2 (en)
BR112014017589A2 (en)
BR112014017636A2 (en)
BR112014017667A2 (en)